Royston Glasspool

Mr. Royston J.
Glasspool is a Chief Executive Officer at VarmX BV, an Independent Director at Relmada Therapeutics, Inc. and a Venture Partner at Agent Capital LLC.
He is on the Board of Directors at Relmada Therapeutics, Inc. and Biotechnology Innovation Organization.
Mr. Glasspool was previously employed as a Chief Executive Officer & Director by Anthos Therapeutics, Inc., an Independent Director by DalCor Pharmaceuticals Canada, Inc., an EVP, Head-Corporate Strategy & Customer Operations by Baxalta, Inc., a VP-Emerging Therapies & Market Development by Baxter BioScience Corp., a Director & Vice President by European Vaccine Manufacturers, and a Head-Marketing, Neuroscience by Novartis AG.
He received his undergraduate degree from Oxford Brookes University, an undergraduate degree from Staffordshire University and a graduate degree from Tufts University.